Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
about
Oral deferiprone for iron chelation in people with thalassaemiaComparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials.Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable StateReal-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.An update on iron chelation therapyCurrent approach to iron chelation in children.A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia.Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.Chelation therapy in cardiovascular disease: an update.Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine.Deferoxamine versus combined therapy for chelating liver, spleen and bone marrow iron in beta-thalassemic patients: a quantitative magnetic resonance imaging study.The effect of combined therapy with deferoxamine and deferiprone on serum ferritin level of beta-thalassemic patients.Study of serum hepcidin in hereditary hemolytic anemias.Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
P2860
Q24200309-2F0CD3BC-8A19-4296-8C6E-1020EEF46C05Q35077670-61B86AC9-E030-4F33-B9EA-9F26874A02FEQ35675094-76316D0A-4496-4164-AA5A-AAC168DBAB92Q35906193-B3622C1D-3278-4B55-9AA0-FC1C2E24A35AQ36393446-289D0E02-9A93-432E-A2BF-B596DD910E9EQ38197269-8E2B823E-B573-4861-AA70-9377FE98CDFDQ38259421-F1181976-5000-4838-9F67-1DD16466FD7FQ38540491-A20A39AF-EF71-4908-AC1E-E1D83479AF2BQ38650293-FF13E8B1-8860-4DFD-857B-59EEA1707AB5Q39260564-1633998A-41C1-454D-B058-4FE6757E5E8CQ39361634-65EFEB64-8FC1-42C2-A047-661DCD1D64AAQ42446307-0BCE078C-6B37-4AC4-9E2D-8562E01DE6D3Q43180472-676D5566-1604-4486-A789-C25F37FE20F7Q45817965-6876B6A6-E352-445B-9D93-DE2C7B13E093Q46246165-FE8921D3-5D53-4EC9-85EA-3AA49EC69ABBQ56389520-5B1D9358-4CD9-43AB-B549-19429297F5D3
P2860
Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
@en
type
label
Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
@en
prefLabel
Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
@en
P2093
P50
P1433
P1476
Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience
@en
P2093
A V Hoffbrand
Amal El-Beshlawy
Azza Mostafa
Chantal Manz
Claudia Tarabishi
Hewida Sobh
Ilham Youssry
Iman Sharaf
Mohammed Naja
Mona Eltagui
P304
P356
10.1007/S00277-008-0471-2
P577
2008-03-20T00:00:00Z